We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $127B
1-Year Est. Return 46.06%
This Fund
S&P 500
This Quarter Est. Return
+0.73%
1 Year Est. Return
+46.06%
3 Year Est. Return
+142.12%
5 Year Est. Return
+190.33%
10 Year Est. Return
+787.47%
AUM
$24.1B
AUM Growth
+$1.97B
Cap. Flow
+$1.42B
Cap. Flow %
5.88%
Top 10 Hldgs %
10.49%
Holding
3,709
New
1,117
Increased
953
Reduced
622
Closed
747

Sector Composition

Rank Sector Weight
1 Healthcare 20.36%
2 Miscellaneous 19.43%
3 Financials 16.99%
4 Technology 14.07%
5 Consumer Discretionary 11.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BHVN
1
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$378M 1.57%
2,718,185
-14,183
-0.5% -$1.77M
BIO icon
2
Bio-Rad Laboratories Class A
BIO
$10.2B
$328M 1.36%
439,344
+4,245
+1% +$3.18M
MSFT icon
3
Microsoft
MSFT
$3.67T
$269M 1.12%
952,690
-103,219
-10% -$30M
TFX icon
4
Teleflex
TFX
$5.81B
$259M 1.08%
688,909
-228,834
-25% -$89.1M
IWM icon
5
CALL
iShares Russell 2000 ETF
IWM
$80.1B
$252M 1.05%
1,153,700
+490,700
+74% +$109M
ABNB icon
6
Airbnb
ABNB
$103B
$234M 0.97%
1,397,048
+436,326
+45% +$66.6M
TMO icon
7
Thermo Fisher Scientific
TMO
$223B
$231M 0.96%
403,753
-96,414
-19% -$52.9M
AMZN icon
8
Amazon
AMZN
$2.77T
$222M 0.92%
1,349,720
-280,200
-17% -$48.3M
GLD icon
9
PUT
SPDR Gold Trust
GLD
$148B
$178M 0.74%
1,082,400
+342,900
+46% +$57.4M
ACN icon
10
Accenture
ACN
$110B
$175M 0.73%
547,476
+185,701
+51% +$60.4M
AAPL icon
11
Apple
AAPL
$4.61T
$172M 0.71%
1,215,008
-93,727
-7% -$13.8M
GLD icon
12
CALL
SPDR Gold Trust
GLD
$148B
$167M 0.69%
1,014,400
+351,900
+53% +$58.9M
SGEN
13
DELISTED
Seagen Inc. Common Stock
SGEN
$162M 0.67%
956,612
+807,977
+544% +$126M
NTRA icon
14
Natera
NTRA
$46.7B
$152M 0.63%
1,359,761
+91,617
+7% +$10.5M
RGEN icon
15
Repligen
RGEN
$9.51B
$150M 0.62%
520,130
-182,784
-26% -$46.9M
UBER icon
16
Uber
UBER
$149B
$142M 0.59%
3,161,190
+2,896,315
+1,093% +$127M
CP icon
17
Canadian Pacific Kansas City
CP
$80.1B
$140M 0.58%
2,148,522
+1,717,217
+398% +$122M
IWM icon
18
PUT
iShares Russell 2000 ETF
IWM
$80.1B
$134M 0.56%
611,000
+22,200
+4% +$4.92M
CRL icon
19
Charles River Laboratories
CRL
$13.4B
$125M 0.52%
302,537
+19,810
+7% +$8.23M
TLT icon
20
CALL
iShares 20+ Year Treasury Bond ETF
TLT
$47.1B
$120M 0.5%
834,800
+607,900
+268% +$90.3M
ZTS icon
21
Zoetis
ZTS
$30.4B
$117M 0.48%
601,137
-350,148
-37% -$70.7M
TECH icon
22
Bio-Techne
TECH
$11.3B
$112M 0.46%
922,480
+611,388
+197% +$74.4M
IBKR icon
23
Interactive Brokers
IBKR
$41.2B
$108M 0.45%
6,935,364
+1,543,672
+29% +$24.3M
SKIN icon
24
SkinHealth Systems
SKIN
$95.9M
$107M 0.44%
+4,113,430
New +$90.5M
WST icon
25
West Pharmaceutical
WST
$23.8B
$106M 0.44%
249,099
+93,783
+60% +$39.5M

Similar funds

Marshall Wace's Q3 2021 Portfolio in Review

As of Q3 2021, Marshall Wace held 3,709 positions worth $24.1B, up 8.9% from $22.1B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Marshall Wace deployed $1.42B of net new capital in Q3 2021, opening 1,117 new positions and adding to 953 existing holdings. Its largest new stake was SkinHealth Systems: 4,113,430 shares worth $107M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Miscellaneous and Financials.

On the sell side, the largest reduction was Biogen, an estimated $210M trimmed.

  • Marshall Wace's largest Q3 2021 buy was SkinHealth Systems: 4,113,430 shares worth $107M.
  • Marshall Wace added most to Uber in Q3 2021, an estimated $127M increase.
  • Marshall Wace's biggest Q3 2021 reduction was Biogen, cutting an estimated $210M.
  • Marshall Wace fully exited Vipshop in Q3 2021, selling an estimated $58.7M.
  • Marshall Wace's ten largest holdings make up 10% of its $24.1B portfolio in Q3 2021.
  • Marshall Wace opened 1,117 new positions and closed 747 in Q3 2021.
  • Marshall Wace's portfolio value rose 8.9% quarter-over-quarter to $24.1B.

Based on Marshall Wace's 13F filing for Q3 2021, filed 15 Nov 2021.